Bosh sahifaPTKFY • OTCMKTS
add
PT Kalbe Farma Unsponsored Indonesia ADR
Yopilish kursi
19,94 $
Yillik diapazon
16,38 $ - 23,73 $
Bozor kapitalizatsiyasi
68,91 trln IDR
Oʻrtacha hajm
1,13 ming
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (IDR) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 7,91 trln | 7,16% |
Joriy xarajat | 2,29 trln | 15,55% |
Sof foyda | 573,28 mlrd | 6,97% |
Sof foyda marjasi | 7,25 | -0,14% |
Har bir ulushga tushum | 12,41 | 7,73% |
EBITDA | 874,81 mlrd | 1,14% |
Amaldagi soliq stavkasi | 23,01% | — |
Balans
Jami aktivlari
Jami passivlari
| (IDR) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 4,32 trln | 45,45% |
Jami aktivlari | 28,75 trln | 5,78% |
Jami passivlari | 4,84 trln | 0,67% |
Umumiy kapital | 23,91 trln | — |
Tarqatilgan aksiyalar | 46,15 mlrd | — |
Narxi/balansdagi bahosi | 0,04 | — |
Aktivlardan daromad | 6,15% | — |
Kapitaldan daromad | 7,16% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (IDR) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 573,28 mlrd | 6,97% |
Operatsiyalardan naqd pul | 1,16 trln | 22,56% |
Sarmoyadan naqd pul | -176,64 mlrd | 33,78% |
Moliyadan naqd pul | -421,11 mlrd | 51,91% |
Naqd pulning sof oʻzgarishi | 481,86 mlrd | 1 978,42% |
Boʻsh pul | 752,00 mlrd | 13,84% |
Haqida
PT Kalbe Farma Tbk, or simply known as Kalbe, is an Indonesian pharmaceutical, healthcare and nutrition company established in 1966. The company has expanded by strategic acquisitions of pharmaceutical companies, becoming an integrated consumer health and nutrition enterprise.
The Kalbe Group has brands in the prescription drugs, OTC drugs, energy drink and nutrition products, distribution arm that reaches over 1 million outlets. Notably, the company produces misoprostol, a drug which is used to treat stomach ulcers but is also widely used in Indonesia as an illegal abortifacient.
Company brands in healthcare and pharmaceutical segments include Promag, Mixagrip, Woods, Komix, Prenagen, Extra Joss and Fitbar.
Kalbe is the largest publicly listed pharmaceutical company in Southeast Asia with around US$5 billion in market capitalization and revenues of over Rp 15 trillion. Wikipedia
Tashkil etilgan
10-sen, 1966
Sayt
Xodimlar soni
12 924
